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Introduction
Chronic disease such as cancer is the most common 
public health problem in the worldwide(Keyghobadi et al., 
2015; Razi et al., 2015) Kidney cancer accounts for about 
3 percent of all cancers (Ferlay et al., 2015). Renal cell 
carcinomas are the most common type of kidney tumor, 
and constitute 80 % of all kidney tumors (Jia et al., 2014).
Based on the report of GLOBOCAN in 2012, 214,000 
and 12,400 new cases of the cancer occur in men and 
women, respectively. This cancer is considered ninth 
and fourteenth common cancer in males and females, 
respectively. It is the sixteenth cause of cancer death in 
the world (Ferlay et al., 2015). Kidney cancer is one of 
the most common cancers in Western countries (Gunes 
et al., 2012). Incidence rate of the cancer is lower in 
African and Southeast Asian countries than eastern and 
northern Europe, Australia and North America (Ferlay et 
al.; Singam et al., 2010). 
In recent years, an increasing trend was observed in 
the incidence and mortality rates worldwide, especially in 
most developed countries (Chow et al., 2010; Tan et al., 
2015). This cancer is one of the public health problems 
in United States (U.S), where increased incidence of this 
cancer has been reported in different ethnic groups (Li 
et al., 2014). 
It is considered the eighth rank of all cancers and the 
twelfth leading cause of death from cancer in Canada (De 
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Abstract
 Background: Kidney cancer has shown an increasing trend in recent decades. This study aimed to determine 
change in the incidence rate between 2003 and 2009 in Iran. Materials and Methods: In this study, national cancer 
registry data were used. Crude incidence rates were calculated per 100,000 and age-standardized incidence rates 
(ASRs) were computed using the direct standardization method and the world standard population. Significant 
trend of incidence rates was examined by the Cochran-Armitage test for linear trend. Results: A total of 6,944 
cases of kidney cancer were reported. The incidence cases increased from 595 patients in 2003 to 1,387 patients 
in 2009. Sex ratio (male to female) was 1.67. ASR also increased from 1.18 in 2003 to 2.52 in 2009 per 100,000, 
but the increasing trend was not significant. Conclusions: A slow increasing trend of incidence rate was observed 
in the study population. This may be due to an increase of risk factors. It is suggested to perform a study on risk 
factors for the cancer. 
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et al., 2014). 
Differences in cancer incidence and mortality rates 
in different regions of the world could indicate the role 
of various risk factors and genetic differences in the 
etiology of this cancer. The most important risk factors 
for the cancer include smoking, obesity, diabetes mellitus, 
insufficient physical activity, and blood pressure (Chow 
et al., 2010; Basiri et al., 2014; Washio et al., 2014b). 
An increase in the incidence of kidney cancer has been 
reported in various parts of the world (Levi et al., 2008; 
Chow et al., 2010; De et al., 2014). No epidemiological 
study has been carried out on the trend of this type of 
cancer in Iran. An increase or decrease in the cancer rate 
over time emphasizes the need to examine its trends for 
better planning. This study aimed to determine the trend of 
the cancer incidence rate between 2003 and 2009 in Iran. 
Materials and Methods
This study was carried out based on existing data, 
obtained from the national report on cancer registry and 
disease management center of ministry of health in Ira. 
The existing data contained data from 41 pathology centers 
of medical university in the country between 2003 and 
2009. All registered cases were studied by each province. 
The incidence rate was calculated as per 100,000 people 
and ASR using direct standardization and the standard 
population of World Health Organization (W.H.O). The 
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data collected is encoding using ICD-O, which related to 
the code C 64-66. The number of cases, and crude and 
standardized incidence rates was also examined by sex 
and each province. Data was analyzed using Cochran - 
Armitage test for linear trend and software of WinPepi 2.1.
Results 
In our study, a total of 6944 cases of kidney cancer 
were diagnosed since the beginning of 2003 until the end 
of 2009. Of the patients, 4352 cases were men (1.86%) 
and 2592 women (1.42%). The highest number of cases 
was detected in both sexes in 2009. The sex ratio in the 
population studied was 1.67. Table1 shows the distribution 
of patients with kidney cancer according to the years when 
the disease has been diagnosed. The incidence of kidney 
cancer during the years studied had a slow increasing trend 
in both sexes (Figure 1). 
There was a difference in standardized incidence 
in these years. The rate increased from 0.96 in 2003 to 
2.05 in 2009 in women, and from 1.39 in 2003 to 2.99 in 
2009 in men. Table 2 summarizes ASR of kidney cancer 
between 2005 and 2009. The ASR was higher in men than 
women in all age groups. It was also high in the older age 
groups, so that age group of 80-84 years has the highest 
ASR in both sexes.
The incidence rate of kidney cancer in both sexes at 
30 provinces is shown that highest incidence rate was 
observed in the provinces of Fars, Tehran, Khuzestan, and 
Chahar-Mahal Bakhtiari.
Discussion
Our findings showed that a slow increasing trend of the 
cancer incidence during years of the study. The incidence 
rate of the cancer was also higher in men than women. 
ASRs of the cancer were 1.18, 1.43, 1.74, 1.97, 2.04, 2.37, 
and 2.4 between 2003 and 2009. 
A series of different environmental and genetic factors 
are effective in the incidence of cancer. If one factor is 
considered, it is not obviously explain an increase or 
decrease of the cancer. The increase of this cancer may 
be due to changes in the pattern of cancer risk factors. 
Improving the cancer registration system in the country 
was also another reason for the increase. 
Other studies also indicated that the incidence cancer 
trend was higher in developed countries than developing 
and less developed countries, as Iran (Chow et al., 2010). 
In a study performed in United States, it was found that 
one of the reasons for the increase of cancer is raising 
aging population (Wallen et al., 2007). 
The incidence trend of the cancer is different according 
to age, race, and various regions of the world. Global 
reports suggest that kidney cancer is associated with an 
increasing trend in most developed countries (Znaor et 
al., 2014).
The cancer incidence rate is different in various 
regions of the world because of different prevalence of 
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Table 2. The ASR of Kidney Cancer by Sex and Age Group, between 2005 and 2009
 2004  2005  2006  2007  2008 
Age group F M F M F M F M F M
0-4 0.88 0.67 0.92 1.08 1.17 0.57 0.77 1.04 1.03 1.07
9-May 0.22 0.26 0.36 0.34 0.27 0.52 0.27 0.31 0.41 0.32
14-Oct 0.02 0.02 0.13 0.1 0.07 0.02 0.15 0.08 0 0.08
15-19 0.02 0.02 0.06 0.04 0.1 0.08 0.1 0.08 0.11 0
20-24 0.03 0.12 0.11 0.18 0.14 0.21 0.2 0.12 0.11 0.12
25-29 0.22 0.1 0.33 0.23 0.48 0.2 0.32 0.27 0.34 0.2
30-34 0.32 0.24 0.24 0.49 0.69 0.69 0.73 0.69 0.82 0.61
35-39 0.67 0.88 1.45 0.88 0.82 1.91 0.82 0.88 0.67 1.01
40-44 1.22 2.1 1.49 2.28 1.91 2.06 1.75 2.76 2.01 2.63
45-49 2.23 3 2.31 4.77 3.17 3.58 3.1 5.15 2.62 3.92
50-54 3.79 8.07 4.37 9.7 3.89 8.84 3.16 10.23 6.43 7.45
55-59 3.88 6.34 5.35 7.06 5.84 8.8 45.96 12.04 7.31 9.98
60-64 6.2 7.18 5.92 6.29 6.07 7.91 7.89 9.94 7.25 14.69
65-69 6.53 7.35 6.05 7.03 4.54 7.62 6.22 7.62 7.55 14.04
70-74 5.78 11.19 5.8 10.55 5.8 12.76 9.09 12.93 8.16 12.63
75-79 4.58 8.66 3.29 9.86 6.57 9.4 7.23 12.21 11.59 12.71
80-84 3.6 19.31 9.03 13.85 3.61 13.85 9.93 23.54 7.95 17.84
85+ 1 1.85 2.02 6.5 1.01 3.71 5.04 8.36 3.76 7.88
Table 1. The Incidence and Frequency of Kidney 
Cancer, 2003-2009
 N (%) N (%)           CIR            ASR  M:F
Years F M F M F M 
2003 228(1.35) 367(1.70) 0.70 1.08 0.96 1.39 1.45
2004 260(1.27) 453(1.69) 0.79 1.31 1.10 1.76 1.60
2005 334(1.36) 569(1..81) 0.97 1.57 1.39 2.08 1.50
2006 395(1.52) 646(1.91) 1.16 1.79 1.58 2.35 1.49
2007 413(1.51) 669(1.93) 1.21 1.86 1.64 2.43 1.48
2008 444(1.31) 779(1.84) 1.30 2.16 1.81 2.93 1.62
2009 518(1.57) 869(2.11) 1.51 2.21 2.05 2.99 1.68
Total 2592(1.42) 4352(1.86) 8.14 11.89 10.41 15.8 1.67
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risk factors for this type of cancer, including obesity, 
hypertension, smoking and insufficient physical activity, 
and exposure to occupational carcinogens (Wilson et 
al., 2008a; Li et al., 2014; Washio et al., 2014a; 2014b). 
Obesity alone is responsible for 25% of the cancer (Wilson 
et al., 2008b). Based on the third report of the statues of 
non-communicable disease risk factors, the prevalence 
of obesity and hypertension in Iran was estimated about 
22.3 and 26.6%, respectively (Esteghamati et al., 2009).
In United States, about 40 percent of all cancers are 
attributed to obesity and overweight (Moore et al., 2005). 
Our study revealed that there was an increase in age groups 
of 70-74 years and 80-84 years. In other words, as age 
increases, incidence of the cancer also increases, similar 
to findings from other studies  (Nepple et al., 2012). Based 
on survey in Iran , the difference of age distribution in both 
sexes was not statistically significant (Basiri et al., 2014). 
In this study, sex ratio was 167. It means that there are 
167 men for every 100 women. In a study in Australia, 
the ratio was 2 to 1 (Luke et al., 2011), and according 
to study in Lebanon, repotting that 75% of the  patients 
having kidney cancer are men (Khafaja et al., 2015). It 
seems that Iranian men more expose to risk factors of 
the cancer than Iranian women. This can lead to a lower 
incidence of the cancer in these women.
There were differences in the incidence rate of the 
cancer in various regions of Iran. This may be due to 
differences in the distribution of the prevalence of risk 
factors associated with this type of cancer such as exposure 
to various industrial chemical materials in industrial cities. 
In conclusion, although the incidence of kidney cancer 
in Iranian population is lower than developed countries, 
the trend in the incidence of kidney cancer is rising. 
The increase is attributed to improvement of national 
cancer registry and changes in risk factors of the cancer. 
Therefore, it is essential to carry out Etiology studies.
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